Aclaris Therapeutics, Inc.
2022 Q1 - 2026 Q1 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 18,470 | 0.5% | 4,925,374 | 3/31/2026 |
| 2024 Q3 | 11/15/2024 | 304 | 0.0% | 264,377 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 291 | 0.0% | 264,377 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 328 | 0.0% | 264,377 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 278 | 0.0% | 264,377 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,811 | 0.1% | 264,377 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 2,742 | 0.2% | 264,377 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,139 | 0.2% | 264,377 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 4,570 | 0.3% | 290,189 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 6,427 | 0.5% | 408,329 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 5,700 | 0.5% | 408,329 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 7,040 | 0.6% | 408,329 | 3/31/2022 |